234 related articles for article (PubMed ID: 31175292)
1. Structural and functional consequences of the STAT5B
de Araujo ED; Erdogan F; Neubauer HA; Meneksedag-Erol D; Manaswiyoungkul P; Eram MS; Seo HS; Qadree AK; Israelian J; Orlova A; Suske T; Pham HTT; Boersma A; Tangermann S; Kenner L; Rülicke T; Dong A; Ravichandran M; Brown PJ; Audette GF; Rauscher S; Dhe-Paganon S; Moriggl R; Gunning PT
Nat Commun; 2019 Jun; 10(1):2517. PubMed ID: 31175292
[TBL] [Abstract][Full Text] [Related]
2. STAT5BN642H is a driver mutation for T cell neoplasia.
Pham HTT; Maurer B; Prchal-Murphy M; Grausenburger R; Grundschober E; Javaheri T; Nivarthi H; Boersma A; Kolbe T; Elabd M; Halbritter F; Pencik J; Kazemi Z; Grebien F; Hengstschläger M; Kenner L; Kubicek S; Farlik M; Bock C; Valent P; Müller M; Rülicke T; Sexl V; Moriggl R
J Clin Invest; 2018 Jan; 128(1):387-401. PubMed ID: 29200404
[TBL] [Abstract][Full Text] [Related]
3. Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia.
Cross NCP; Hoade Y; Tapper WJ; Carreno-Tarragona G; Fanelli T; Jawhar M; Naumann N; Pieniak I; Lübke J; Ali S; Bhuller K; Burgstaller S; Cargo C; Cavenagh J; Duncombe AS; Das-Gupta E; Evans P; Forsyth P; George P; Grimley C; Jack F; Munro L; Mehra V; Patel K; Rismani A; Sciuccati G; Thomas-Dewing R; Thornton P; Virchis A; Watt S; Wallis L; Whiteway A; Zegocki K; Bain BJ; Reiter A; Chase A
Leukemia; 2019 Feb; 33(2):415-425. PubMed ID: 30573779
[TBL] [Abstract][Full Text] [Related]
4. A Recurrent
Kieslinger M; Swoboda A; Kramer N; Freund P; Pratscher B; Neubauer HA; Steinborn R; Wolfesberger B; Fuchs-Baumgartinger A; Moriggl R; Burgener IA
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680385
[TBL] [Abstract][Full Text] [Related]
5. Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia.
Rajala HL; Eldfors S; Kuusanmäki H; van Adrichem AJ; Olson T; Lagström S; Andersson EI; Jerez A; Clemente MJ; Yan Y; Zhang D; Awwad A; Ellonen P; Kallioniemi O; Wennerberg K; Porkka K; Maciejewski JP; Loughran TP; Heckman C; Mustjoki S
Blood; 2013 May; 121(22):4541-50. PubMed ID: 23596048
[TBL] [Abstract][Full Text] [Related]
6. The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse.
Bandapalli OR; Schuessele S; Kunz JB; Rausch T; Stütz AM; Tal N; Geron I; Gershman N; Izraeli S; Eilers J; Vaezipour N; Kirschner-Schwabe R; Hof J; von Stackelberg A; Schrappe M; Stanulla M; Zimmermann M; Koehler R; Avigad S; Handgretinger R; Frismantas V; Bourquin JP; Bornhauser B; Korbel JO; Muckenthaler MU; Kulozik AE
Haematologica; 2014 Oct; 99(10):e188-92. PubMed ID: 24972766
[No Abstract] [Full Text] [Related]
7. Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.
Küçük C; Jiang B; Hu X; Zhang W; Chan JK; Xiao W; Lack N; Alkan C; Williams JC; Avery KN; Kavak P; Scuto A; Sen E; Gaulard P; Staudt L; Iqbal J; Zhang W; Cornish A; Gong Q; Yang Q; Sun H; d'Amore F; Leppä S; Liu W; Fu K; de Leval L; McKeithan T; Chan WC
Nat Commun; 2015 Jan; 6():6025. PubMed ID: 25586472
[TBL] [Abstract][Full Text] [Related]
8. Enhanced T cell lymphoma in NOD.Stat5b transgenic mice is caused by hyperactivation of Stat5b in CD8+ thymocytes.
Chen B; Yi B; Mao R; Liu H; Wang J; Sharma A; Peiper S; Leonard WJ; She JX
PLoS One; 2013; 8(2):e56600. PubMed ID: 23457589
[TBL] [Abstract][Full Text] [Related]
9. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis.
Nieborowska-Skorska M; Wasik MA; Slupianek A; Salomoni P; Kitamura T; Calabretta B; Skorski T
J Exp Med; 1999 Apr; 189(8):1229-42. PubMed ID: 10209040
[TBL] [Abstract][Full Text] [Related]
10. STAT5B
Klein K; Witalisz-Siepracka A; Maurer B; Prinz D; Heller G; Leidenfrost N; Prchal-Murphy M; Suske T; Moriggl R; Sexl V
Leukemia; 2019 Sep; 33(9):2336-2340. PubMed ID: 30967617
[No Abstract] [Full Text] [Related]
11. Severe growth deficiency is associated with STAT5b mutations that disrupt protein folding and activity.
Varco-Merth B; Feigerlová E; Shinde U; Rosenfeld RG; Hwa V; Rotwein P
Mol Endocrinol; 2013 Jan; 27(1):150-61. PubMed ID: 23160480
[TBL] [Abstract][Full Text] [Related]
12. Rare occurrence of a STAT5B N642H mutation in adult T-cell acute lymphoblastic leukemia.
Ma X; Wen L; Wu L; Wang Q; Yao H; Wang Q; Ma L; Chen S
Cancer Genet; 2015; 208(1-2):52-3. PubMed ID: 25749351
[No Abstract] [Full Text] [Related]
13. Constitutive activation of STAT5 by a point mutation in the SH2 domain.
Ariyoshi K; Nosaka T; Yamada K; Onishi M; Oka Y; Miyajima A; Kitamura T
J Biol Chem; 2000 Aug; 275(32):24407-13. PubMed ID: 10823841
[TBL] [Abstract][Full Text] [Related]
14. A novel missense mutation in the SH2 domain of the STAT5B gene results in a transcriptionally inactive STAT5b associated with severe IGF-I deficiency, immune dysfunction, and lack of pulmonary disease.
Scaglia PA; Martínez AS; Feigerlová E; Bezrodnik L; Gaillard MI; Di Giovanni D; Ballerini MG; Jasper HG; Heinrich JJ; Fang P; Domené HM; Rosenfeld RG; Hwa V
J Clin Endocrinol Metab; 2012 May; 97(5):E830-9. PubMed ID: 22419735
[TBL] [Abstract][Full Text] [Related]
15. High activation of STAT5A drives peripheral T-cell lymphoma and leukemia.
Maurer B; Nivarthi H; Wingelhofer B; Pham HTT; Schlederer M; Suske T; Grausenburger R; Schiefer AI; Prchal-Murphy M; Chen D; Winkler S; Merkel O; Kornauth C; Hofbauer M; Hochgatterer B; Hoermann G; Hoelbl-Kovacic A; Prochazkova J; Lobello C; Cumaraswamy AA; Latzka J; Kitzwögerer M; Chott A; Janikova A; Pospíšilova Š; Loizou JI; Kubicek S; Valent P; Kolbe T; Grebien F; Kenner L; Gunning PT; Kralovics R; Herling M; Müller M; Rülicke T; Sexl V; Moriggl R
Haematologica; 2020; 105(2):435-447. PubMed ID: 31123029
[TBL] [Abstract][Full Text] [Related]
16. A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling.
Bessette K; Lang ML; Fava RA; Grundy M; Heinen J; Horne L; Spolski R; Al-Shami A; Morse HC; Leonard WJ; Kelly JA
Blood; 2008 Jan; 111(1):344-50. PubMed ID: 17890450
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel STAT5B mutations and characterization of TCRβ signatures in CD4+ T-cell large granular lymphocyte leukemia.
Bhattacharya D; Teramo A; Gasparini VR; Huuhtanen J; Kim D; Theodoropoulos J; Schiavoni G; Barilà G; Vicenzetto C; Calabretto G; Facco M; Kawakami T; Nakazawa H; Falini B; Tiacci E; Ishida F; Semenzato G; Kelkka T; Zambello R; Mustjoki S
Blood Cancer J; 2022 Feb; 12(2):31. PubMed ID: 35210405
[TBL] [Abstract][Full Text] [Related]
18. Frequent STAT5B mutations in γδ hepatosplenic T-cell lymphomas.
Nicolae A; Xi L; Pittaluga S; Abdullaev Z; Pack SD; Chen J; Waldmann TA; Jaffe ES; Raffeld M
Leukemia; 2014 Nov; 28(11):2244-8. PubMed ID: 24947020
[No Abstract] [Full Text] [Related]
19. Chronic eosinophilic leukemia with recurrent STAT5B N642H mutation-An entity with features of myelodysplastic syndrome/ myeloproliferative neoplasm overlap.
Sreedharanunni S; Jamwal M; Balakrishnan A; Aravindan AV; Sharma R; Singh N; Rajpal S; Singla S; Khadwal AR; Ahluwalia J; Malhotra P; Das R
Leuk Res; 2022 Jan; 112():106753. PubMed ID: 34856508
[No Abstract] [Full Text] [Related]
20. A mutant signal transducer and activator of transcription 5b, associated with growth hormone insensitivity and insulin-like growth factor-I deficiency, cannot function as a signal transducer or transcription factor.
Fang P; Kofoed EM; Little BM; Wang X; Ross RJ; Frank SJ; Hwa V; Rosenfeld RG
J Clin Endocrinol Metab; 2006 Apr; 91(4):1526-34. PubMed ID: 16464942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
